Telemonitoring Program in the Vulnerable Phase After Hospitalization for Heart Failure
Heart Failure, Acute Heart Failure
About this trial
This is an interventional treatment trial for Heart Failure focused on measuring telemonitoring, Heart Failure, Vulnerable phase
Eligibility Criteria
Inclusion Criteria: Age ≥ 18 years Hospitalized for acute heart failure (regardless of the level of left ventricular ejection fraction) within 24 hours of discharge, or with a history of hospitalization for acute HF within 10 days prior to randomization. Own a smartphone (Smartphone) with internet Ability to speak and read Spanish. Residence in the metropolitan area of Buenos Aires Exclusion Criteria: Pregnancy Alcohol or drug abuse Kidney failure in hemodialysis, Inability to use the app (Ex: cognitive impairment, lack of social support, lack of ability to communicate) Active cancer Life expectancy less than 1 year Candidates for care home or institutional end of life Severe psychiatric illness Planned cardiac surgery Patient unable or unwilling to give informed consent to participate.
Sites / Locations
- Instituto Cardiovascular de Buenos AiresRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
Placebo Comparator
Telemonitoring program with electronic alerts + Standard of care
Standard of care